PLoS ONE (Jan 2017)

Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function.

  • Chih-Hsuan Yen,
  • Chung-Lieh Hung,
  • Ping-Ying Lee,
  • Jui-Peng Tsai,
  • Yau-Huei Lai,
  • Cheng-Huang Su,
  • Hung-I Yeh,
  • Charles Jia-Yin Hou,
  • Kuo-Liong Chien

DOI
https://doi.org/10.1371/journal.pone.0183747
Journal volume & issue
Vol. 12, no. 9
p. e0183747

Abstract

Read online

Central arterial stiffness has been shown to play a key role in cardiovascular disease. However, evidence regarding such arterial stiffness from various arterial segments in relation to B-type natriuretic peptide (BNP) remains elusive.A total of 1255 participants (47.8% men; mean age: 62.6 ± 12.3 [SD] years) with preserved left ventricular function (ejection fraction ≥50%) and ≥1 risk factors were consecutively studied. Arterial pulse wave velocity (PWV) by automatic device (VP-2000; Omron Healthcare) for heart-femoral (hf-PWV), brachial-ankle (ba-PWV), and heart-carotid (hc-PWV) segments were obtained and related to BNP concentrations (Abbott Diagnostics, Abbott Park, IL, USA).Subjects in the highest hf-PWV quartile were older and had worse renal function and higher blood pressure (all P 100 pg/ml (both P < 0.01), but only hf-PWV presented significant integrated discrimination improvement to predict risk for BNP concentrations (0.7%, P = 0.029).A significant segmental PWV associated with biomarker BNP concentrations suggests that arterial stiffness is associated with myocardial damage.